Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04172675 |
|---|---|
| Brief Title: | A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) |
| First Submitted : | November 20, 2019 |
| First Submitted that Met QC Criteria : | November 20, 2019 |
| First Posted : | November 21, 2019 |
| Last Update Submitted that Met QC Criteria : | March 26, 2024 |
| Last Update Posted : | March 27, 2024 |